Cupid Medical And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 35.02%
- Ebitda 35.02%
- Net Worth -7.13%
- Total Assets -7.13%
About Cupid Medical And Research Centre
Cupid Medical And Research Centre Private Limited (CMARCPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 September 2008 and has a history of 16 years and five months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Durgesh Garg and Pawan Bansal serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100MH2008PTC186423
- Company No.
186423
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2008
- Date of AGM
02 Mar 2022
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Cupid Medical And Research Centre?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Durgesh Garg  | Director | 02-Sep-2008 | Current |
| Pawan Bansal | Director | 02-Sep-2008 | Current |
Financial Performance of Cupid Medical And Research Centre.
Cupid Medical And Research Centre Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 35.02% increase in profit. The company's net worth dipped by a decrease of 7.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cupid Medical And Research Centre?
In 2021, Cupid Medical And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tycoon Finlease Private LimitedDurgesh Garg is a mutual person
- Nayan Foam And Mattresses Private Limited
Durgesh Garg is a mutual person
- Dhansanchay Exports And Trading Private Limited
Pawan Bansal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cupid Medical And Research Centre?
Unlock and access historical data on people associated with Cupid Medical And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cupid Medical And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cupid Medical And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.